373,180 Shares in Corteva, Inc. $CTVA Acquired by Dearborn Partners LLC

Dearborn Partners LLC bought a new stake in Corteva, Inc. (NYSE:CTVA) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 373,180 shares of the company’s stock, valued at approximately $31,605,000. Corteva comprises about 1.5% of Dearborn Partners LLC’s investment portfolio, making the stock its 16th largest position. Dearborn Partners LLC owned about 0.06% of Corteva at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in CTVA. Brighton Jones LLC boosted its holdings in Corteva by 307.2% during the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after acquiring an additional 11,760 shares during the period. Woodline Partners LP boosted its stake in shares of Corteva by 40.3% in the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after purchasing an additional 16,644 shares during the period. EverSource Wealth Advisors LLC grew its holdings in shares of Corteva by 62.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after purchasing an additional 980 shares in the last quarter. Cresset Asset Management LLC grew its holdings in shares of Corteva by 2.6% in the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock valued at $526,000 after purchasing an additional 181 shares in the last quarter. Finally, Jump Financial LLC purchased a new stake in Corteva during the 2nd quarter worth approximately $1,464,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Stock Down 0.7%

CTVA opened at $82.27 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97. The business’s 50-day simple moving average is $82.58 and its 200-day simple moving average is $80.52. The stock has a market capitalization of $54.89 billion, a P/E ratio of 54.48, a price-to-earnings-growth ratio of 2.54 and a beta of 0.57.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company’s revenue was down 1.2% compared to the same quarter last year. During the same period in the prior year, the company earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio is currently 47.68%.

Analyst Ratings Changes

Several equities analysts have commented on CTVA shares. BMO Capital Markets raised their price target on shares of Corteva from $95.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, August 3rd. Oppenheimer increased their price objective on Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, July 23rd. UBS Group decreased their target price on Corteva from $89.00 to $85.00 and set a “neutral” rating for the company in a report on Tuesday, August 18th. JPMorgan Chase & Co. boosted their target price on Corteva from $77.00 to $83.00 and gave the stock a “neutral” rating in a research note on Monday, August 3rd. Finally, Royal Bank Of Canada upped their price target on Corteva from $97.00 to $103.00 and gave the stock an “outperform” rating in a report on Tuesday, July 21st. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $91.50.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.